Short Interest in Summit Therapeutics Inc. (NASDAQ:SMMT) Rises By 18.6%

Should You Buy or Sell Roper Technologies Stock? Get The Latest ROP Stock Forecast, Price Target, Dividend Info, Headlines, Short Interest at MarketBeat.

Related Keywords

Canada ,Christopher Wright ,Robertw Baird ,Richardf Wallman ,Kinneret Advisory ,Wolfe Research ,Application Software ,Barclays ,Roper Technologies Inc ,Royal Bank ,Securities Exchange Commission ,Aderant ,Network Software ,Silvercrest Asset Management Group ,Roper Technologies Company Profile ,Menard Financial Group ,Technology Enabled Products ,Roper Technologies ,Get Rating ,Moderate Buy ,Director Richard ,Exchange Commission ,Director Christopher Wright ,Asset Management Group ,Investment Advisers ,Financial Group ,Technology Enabled ,Data Innovations ,Frontline Education ,Roper Technologies Daily ,